Previously, combination of t-AUCB and Hsp27 phosphorylation inhibitor has been reported to synergistically inhibit glioblastoma cell growth in vitro by us [15], and combination of t-AUCB and COX-2 inhibitor has been shown to synergistically inhibit primary tumor growth by others [16]. The gene discussed is PTGS2; the disease is neoplasm.